Biomarin

5 FDA approval decisions to watch in the fourth quarter
BioPharma Dive
Sun, 10/3/21 - 08:32 pm
FDA
vaccines
COVID-19
Pfizer
BioNTech
JNJ
cilta cel
Biomarin
vosoritide
Intra-Cellular Therapies
lumateperone
Moderna Therapeutics
FDA halts tests of BioMarin drug amid heightened focus on gene therapy safety
BioPharma Dive
Tue, 09/7/21 - 10:51 am
FDA
Biomarin
gene therapy
phenylketonuria
clinical trials
BioMarin stands tall with first approved drug for rare disease that causes dwarfism
MedCity News
Sat, 08/28/21 - 08:57 pm
Biomarin
Europe
achondroplasia
dwarfism
Incyte
MorphoSys
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
Motley Fool
Fri, 08/20/21 - 10:57 am
Biomarin
Voxzogo
BioMarin gears up for two 'transformational' launches, Voxzogo and Roctavian: CEO
Fierce Pharma
Mon, 08/2/21 - 09:36 pm
Biomarin
Pharma CEOs
J.J. Bienaimé
BioMarin's gene therapy lead jumps ship to rival biotech Vedere Bio II
Fierce Biotech
Tue, 06/22/21 - 11:11 am
Vedere Bio II
gene therapy
Biomarin
BioMarin (BMRN) Hemophilia Gene Therapy Gets FDA's RMAT Tag
Yahoo/Zacks.com
Tue, 03/9/21 - 10:37 am
Biomarin
gene therapy
hemophilia A
valoctocogene roxaparvovec
FDA
RMAT
Gene therapy for hemophilia: So close, yet so far away
BioPharma Dive
Thu, 01/28/21 - 11:18 pm
hemophilia
hemophilia A
hemophilia B
gene therapy
Biomarin
uniQure
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
BioMarin tries to get hemophilia gene therapy back on track with positive data
BioPharma Dive
Mon, 01/11/21 - 10:40 am
Biomarin
hemophilia A
gene therapy
clinical trials
Roctavian
10 Biopharma Stories to Look Forward to in 2021
BioSpace
Sun, 01/3/21 - 04:39 pm
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
#ASH20 Best of the Rest: Pfizer, Sangamo launch a durability charge at BioMarin in hem A; The data behind Merck's $4.5B buyout
Endpoints
Mon, 12/7/20 - 10:32 am
ASH2020
uniQure
hemophilia A
Sangamao
gene therapy
Biomarin
Deep Genomics hits the partnering ground running with BioMarin deal
Fierce Biotech
Tue, 11/17/20 - 10:50 am
Deep Genomics
Biomarin
drug discovery
artificial intelligence
How BioMarin Beat Expectations in Q3
Motley Fool
Fri, 11/6/20 - 09:55 am
Biomarin
hemophilia A
earnings
BioMarin nabs FDA review for dwarfism drug vosoritide, forgoes AdComm as it eyes 2021 approval
Fierce Biotech
Wed, 11/4/20 - 10:57 pm
Biomarin
FDA
vosoritide
dwarfism
BioMarin (BMRN) Files NDA for Vosoritide to Treat Dwarfism
Yahoo/Zacks.com
Fri, 08/21/20 - 11:56 am
Biomarin
FDA
achondroplasia
dwarfism
2 major FDA rejections leave some pharma investors worried about intensification of regulations
Beckers Hospital Review
Thu, 08/20/20 - 10:51 pm
FDA
drug approvals
drug development
Gilead Sciences
Biomarin
Is valrox dead?
EP Vantage
Thu, 08/20/20 - 11:09 am
Biomarin
hemophilia A
valrox
gene therapy
Roche
Pfizer
FDA
FDA gets out its red pen again, rejecting BioMarin's gene therapy valrox amid durability worries
Fierce Biotech
Wed, 08/19/20 - 09:28 am
Biomarin
FDA
valrox
hemophilia A
How Biomarin Beat Expectations in Q2
Motley Fool
Wed, 08/5/20 - 09:46 am
Biomarin
earnings

Pages